Correvio Pharma Corp. Capital Expenditures
Correvio Pharma Corp. reported Capital Expenditures of $129.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-04-30
| Period end | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|
| 2019-12-31 | $129.00K 20-F · filed 2020-04-30 |
| 2018-12-31 | $284.00K 20-F · filed 2020-04-30 |
| 2017-12-31 | $5.00K 20-F · filed 2020-04-30 |
| 2016-12-31 | $9.00K 20-F · filed 2018-04-30 |
| 2015-12-31 | $132.00K 20-F · filed 2018-04-30 |
| 2014-12-31 | $522.00K 40-F · filed 2016-03-29 |
| 2013-12-31 | $39.00K 40-F · filed 2015-03-27 |
| 2012-12-31 | $141.00K 40-F/A · filed 2014-04-30 |
| 2011-12-31 | $676.00K 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $274.00K 20-F/A · filed 2013-04-18 |